{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:22Z","timestamp":1786996102755,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pupt.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T17:24:36Z","timestamp":1512840276000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2017.11.009_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09059180.00003510","article-title":"Mucoactive drugs","volume":"19","author":"Balsamo","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2017.11.009_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1183\/09059180.00003610","article-title":"Mucoactive therapy in COPD","volume":"19","author":"Decramer","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2017.11.009_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/17476348.2016.1121105","article-title":"Oxidation pathway and exacerbations in COPD: the role of NAC","volume":"10","author":"Matera","year":"2016","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.pupt.2017.11.009_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1389450111314020007","article-title":"Antioxidants and mucolytics in COPD management: when (if ever) and in whom?","volume":"14","author":"Hillas","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pupt.2017.11.009_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1517\/17425250902814790","article-title":"Erdosteine: its relevance in COPD treatment","volume":"5","author":"Moretti","year":"2009","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.pupt.2017.11.009_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00408-007-9065-3","article-title":"Erdosteine: antitussive and anti-inflammatory effects","volume":"186","author":"Dal Negro","year":"2008","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2017.11.009_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5414\/CPP49041","article-title":"Erdosteine affects eicosanoid production in COPD","volume":"49","author":"Dal Negro","year":"2011","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2017.11.009_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pupt.2016.09.007","article-title":"Erdosteine reduces the exercise-induced oxidative stress in patients with severe COPD: results of a placebo-controlled trial","volume":"41","author":"Dal Negro","year":"2016","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2017.11.009_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/17476348.1.3.307","article-title":"Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease","volume":"1","author":"Moretti","year":"2007","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.pupt.2017.11.009_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pupt.2009.10.002","article-title":"The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data","volume":"23","author":"Cazzola","year":"2010","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2017.11.009_bib11","unstructured":"Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0029749\/."},{"key":"10.1016\/j.pupt.2017.11.009_bib12","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2147\/COPD.S87091","article-title":"Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD","volume":"10","author":"Moretti","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2017.11.009_bib13","doi-asserted-by":"crossref","first-page":"1700711","DOI":"10.1183\/13993003.00711-2017","article-title":"Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study","volume":"50","author":"Dal Negro","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2017.11.009_bib14","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med."},{"key":"10.1016\/j.pupt.2017.11.009_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.pupt.2017.11.009_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2016.07.009","article-title":"Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"40","author":"Rogliani","year":"2016","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2017.11.009_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1753465808098224","article-title":"Antioxidant therapeutic advances in COPD","volume":"2","author":"Rahman","year":"2008","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.pupt.2017.11.009_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2011.11.004","article-title":"Pharmacological antioxidant strategies as therapeutic interventions for COPD","volume":"1822","author":"Rahman","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pupt.2017.11.009_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001287.pub5","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2017.11.009_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chest.2016.02.646","article-title":"A systematic review with meta-analysis of dual bronchodilation with LAMA\/LABA for the treatment of stable COPD","volume":"149","author":"Calzetta","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2017.11.009_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis\u2013a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLos One"},{"key":"10.1016\/j.pupt.2017.11.009_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pupt.2017.11.009_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pupt.2017.11.009_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/16000617.00002215","article-title":"Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis","volume":"24","author":"Cazzola","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2017.11.009_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.pupt.2017.11.009_bib26","first-page":"521","article-title":"Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion","volume":"16","author":"Aubier","year":"1999","journal-title":"Rev. Mal. Respir."},{"key":"10.1016\/j.pupt.2017.11.009_bib27","first-page":"612","article-title":"Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study)","volume":"33","author":"Marchioni","year":"1995","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2017.11.009_bib28","first-page":"89","article-title":"Mucolytic activity of erdosteine: double blind clinical trial vs. placebo","volume":"47","author":"Bisetti","year":"1995","journal-title":"Arch. Med. Int."},{"key":"10.1016\/j.pupt.2017.11.009_bib29","first-page":"171","article-title":"Erdosteine or placebo combined with co-trimoxazole in the treatment of hypersecretive infectious bronchitis: a double blind clinical trial","volume":"12","author":"Hotzinger","year":"1991","journal-title":"Med. Pr."},{"key":"10.1016\/j.pupt.2017.11.009_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thx.43.8.585","article-title":"Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis","volume":"43","author":"Ricevuti","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2017.11.009_bib31","first-page":"219","article-title":"Prevention of exacerbations in chronic bronchitic patients with erdosteine","volume":"12","author":"Fioretti","year":"1991","journal-title":"Med. Pr."},{"key":"10.1016\/j.pupt.2017.11.009_bib32","first-page":"143","article-title":"The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study","volume":"30","author":"Moretti","year":"2004","journal-title":"Drugs Under Exp. Clin. Res."},{"key":"10.1016\/j.pupt.2017.11.009_bib33","first-page":"481","article-title":"Efic\u00e1cia e tolerabilidade da erdoste\u00edna na doen\u00e7a pulmonar obstrutiva cr\u00f4nica","volume":"57","author":"de Castro Pereira","year":"2000","journal-title":"Rev. Bras. Med."},{"key":"10.1016\/j.pupt.2017.11.009_bib34","article-title":"Global initiative for chronic obstructive Lung disease","author":"GOLD","year":"2017","journal-title":"Global Strategy for Diagnosis,Management, and Prevention of COPD"},{"issue":"7","key":"10.1016\/j.pupt.2017.11.009_bib35","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2017.11.009_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/15412555.2017.1347918","article-title":"Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis","volume":"14","author":"Cazzola","year":"2017","journal-title":"COPD"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917302535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917302535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T16:11:44Z","timestamp":1570464704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553917302535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":36,"alternative-id":["S1094553917302535"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2017.11.009","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}